Wealthspire Advisors (New York)’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-993
Closed -$122K 1382
2025
Q3
$122K Buy
+993
New +$123K ﹤0.01% 953
2024
Q4
Sell
-1,328
Closed -$216K 802
2024
Q3
$216K Buy
+1,328
New +$197K ﹤0.01% 694
2024
Q1
Sell
-1,489
Closed -$212K 647
2023
Q4
$212K Buy
+1,489
New +$199K ﹤0.01% 605
2022
Q1
Sell
-2,496
Closed -$435K 454
2021
Q4
$435K Buy
+2,496
New +$416K 0.01% 348
2021
Q2
Sell
-1,820
Closed -$351K 429
2021
Q1
$351K Buy
1,820
+384
+27% +$73.9K 0.01% 506
2020
Q4
$290K Buy
1,436
+414
+41% +$85.7K 0.01% 447
2020
Q3
$215K Buy
+1,022
New +$228K 0.01% 289
2020
Q2
Sell
-2,755
Closed -$477K 317
2020
Q1
$477K Buy
+2,755
New +$455K 0.02% 300
2019
Q1
Sell
-82
Closed -$13K 186
2018
Q4
$13K Buy
+82
New +$12.8K ﹤0.01% 433

Other funds holding CLX

Wealthspire Advisors (New York)'s CLX Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Clorox (CLX) in Q4 2025, closing a stake of 993 shares — an estimated $122K sold.

Wealthspire Advisors (New York) first reported a position in CLX in Q4 2018 and held it in 9 quarters. The position peaked at $477K in Q1 2020. 1,051 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 993 Clorox shares in Q4 2025, an estimated $122K.
  • Wealthspire Advisors (New York) first reported a position in Clorox in Q4 2018 and held it in 9 quarters.
  • Wealthspire Advisors (New York)'s Clorox position peaked at $477K in Q1 2020.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.